AstraZeneca (GB:AZN) has released an update.
AstraZeneca has announced a $3.5 billion investment in expanding its research and manufacturing capabilities in the United States, creating over a thousand new high-skilled jobs. This strategic move aims to strengthen the company’s presence in its largest market, contributing significantly to its goal of reaching $80 billion in total revenue by 2030. With state-of-the-art facilities planned across several states, AstraZeneca is set to enhance its development of innovative therapies.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.
